Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening

被引：46

作者：

Usui, Taikou ^{[1
]}

Ban, Hyun Seung ^{[1
]}

Kawada, Junpei ^{[1
]}

Hirokawa, Takatsugu ^{[2
]}

Nakamura, Hiroyuki ^{[1
]}

机构：

[1] Gakushuin Univ, Fac Sci, Dept Chem, Tokyo 1718588, Japan

[2] Inst Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo 1350064, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 01期

关键词：

D O I：

10.1016/j.bmcl.2007.10.084

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of indenopyrazoles 8 and 9 were designed and synthesized as EGFR tyrosine kinase inhibitors by in silico high-throughput screening. Compounds 8b and 8d showed significant inhibition of A431 cell growth (GI(50) = 0.062 and 0.057 mu M, respectively). Compounds 8b and 9a showed inhibitory activity toward both EGFR and VEGFR-2 (KDR) tyrosine kinases, whereas 8d inhibited VEGFR-2 tyrosine kinase, exclusively. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：285 / 288

页数：4

共 50 条

[21] QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors
Kang, Cong-Min
Liu, Dong-Qing
Zhao, Xu-Hao
Dai, Ying-Jie
Cheng, Jia-Gao
Lv, Ying-Tao
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (01) : 103 - 109
[22] High-Throughput Virtual Screening Using Quantum Mechanical Probes: Discovery of Selective Kinase Inhibitors
Zhou, Ting
Caflisch, Amedeo
CHEMMEDCHEM, 2010, 5 (07) : 1007 - 1014
[23] Discovery of novel inhibitors of the galactokinase from high throughput and in silico screening
Shen, Min
Hu, Xin
Zhang, Ya-Qin
Liu, Li
Boxer, Matthew
Hall, Matthew
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[24] An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2
Meirson, Tomer
Samson, Abraham O.
Gil-Henn, Hava
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1535 - 1557
[25] IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening
Tidten-Luksch, Naomi
Grimaldi, Raffaella
Torrie, Leah S.
Frearson, Julie A.
Hunter, William N.
Brenk, Ruth
PLOS ONE, 2012, 7 (04):
[26] A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Xiao, Ting
Liu, Rui
Proud, Christopher G.
Wang, Ming-Wei
ACTA PHARMACEUTICA SINICA B, 2016, 6 (06) : 557 - 563
[27] A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Ting Xiao
Rui Liu
Christopher G.Proud
Ming-Wei Wang
Acta Pharmaceutica Sinica B, 2016, 6 (06) : 557 - 563
[28] Synthesis of 4-Anilinoquinazoline-Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR-2
Bang, Keuk Chan
Song, Tae Hun
Park, Young Jin
Lee, Jong Soo
Jun, Seungah
Jung, Seung Hyun
Chun, Young-Jin
Kim, Ha Hyung
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2018, 39 (01): : 123 - 125
[29] Novel VEGFR-2 kinase inhibitors for the treatment of cancer
Boyer, SJ
Burke, JM
Brennan, CR
Brini, W
Collibee, W
Dixon, JA
Dumas, J
Ehrgott, F
Hatoum-Mokdad, H
Hong, ZQ
Kluender, HC
Lee, W
Ma, X
Reeves, R
Sibley, RN
Turner, T
Wong, W
Zhang, YL
Brink, C
Carter, C
Chang, Y
Chien, DS
Cortes, C
Elting, J
Jones, RM
McHugh, M
Natrillo, A
Polony, B
Vincent, P
Wilkie, D
Webb, D
Zhu, GC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2505 - U2505
[30] Photoactivatable Caged Prodrugs of VEGFR-2 Kinase Inhibitors
Pinchuk, Boris
Horbert, Rebecca
Doebber, Alexander
Kuhl, Lydia
Peifer, Christian
MOLECULES, 2016, 21 (05):

← 1 2 3 4 5 →